CHICAGO--(BUSINESS WIRE)--Veradigm™, an Allscripts (NASDAQ: MDRX), business unit dedicated to simplifying healthcare with data driven health insights and technologies to help manage costs and improve health outcomes, announced today that it has partnered with the American College of Cardiology (ACC) to power the next generation of real-world research on behalf of cardiovascular disease and diabetes patients around the world. As part of this partnership, Veradigm will operate the PINNACLE Registry®, which focuses on coronary artery disease, hypertension, heart failure, atrial fibrillation and diabetes in the outpatient setting, and the Diabetes Collaborative Registry, the first global, cross-specialty clinical registry designed to track and improve the quality of diabetes and metabolic care across the primary care and specialty care continuum from the American College of Cardiology.
PINNACLE and Diabetes Collaborative Registries will extend Veradigm’s EHR-enabled ambulatory research network to create a large-scale chronic disease network with more than 250,000 clinicians and 150 million patients including Veradigm partner data sets in the United States. In addition to integrating Veradigm’s technology, data and analytic capabilities with the ACC’s PINNACLE Registry and Diabetes Collaborative Registry, the partnership will leverage Veradigm’s large specialist and primary care provider network, utilizing its electronic health record platforms to bring ACC’s clinical guidelines, decision pathways, education and wealth of provider and patient engagement tools to the point of care.
“It is essential that clinicians have access to the most comprehensive clinical information that technology allows for to provide their patients with the best possible care,” said Richard J. Kovacs, MD, FACC, President of the American College of Cardiology. “Through this partnership, we are committing to innovative ways to further the field of cardiology and fulfilling our mission to transform cardiovascular care and improve heart health by delivering a wider breadth of clinical tools and research opportunities to registry participants.”
Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.
This relationship provides value for patients and providers of healthcare across the US health care ecosystem, while maintaining all the benefits of current participation in the PINNACLE Registry and Diabetes Collaborative Registry. Stephanie Reisinger, GM & VP Veradigm says, “physicians will have greater opportunities to participate in research studies and have increased access to evidence-based medicine and tools and can expect clinical workflow solutions to be deployed more seamlessly at the point-of-care.”